Skip to main content

Table 2 Medication

From: Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot study

Medication Baseline (n=17) Pre-surgery (n=13) Changes in medication from baseline to pre-surgery assessment
Started Stopped Dose reduced Dose increased Medication type changed
Diabetes medication        
Insulin 7 (41%) 8 (62%) 2 (15%) 0 (0%) 4 (31%) 1 (8%) 1 (8%)
Metformin 13 (76%) 10 (77%) 0 (0%) 0 (0%) 1 (8%) 0 (0%) 0 (0%)
Sulfonylurea 3 (18%) 0 (0%) 0 (0%) 2 (15%) 0 (0%) 0 (0%) 0 (0%)
SGLT2 Inhibitor 3 (18%) 7 (54%) 4 (31%) 0 (0%) 0 (0%) 0 (0%) 1 (8%)
DPP4 inhibitor 3 (18%) 2 (15%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
GLP-1 receptor agonist 1 (6%) 2 (15%) 2 (15%) 1 (8%) 0 (0%) 0 (0%) 0 (0%)
Other medication        
Statin 14 (82%) 12 (92%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (15%)
ACE inhibitor 7 (41%) 3 (23%) 0 (0%) 2 (15%) 0 (0%) 0 (0%) 0 (0%)
ARB 4 (24%) 1 (8%) 0 (0%) 3 (23%) 0 (0%) 0 (0%) 0 (0%)